ADRs related to unapproved clinical products: TGA changes

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2017年 / 1648卷 / 1期
关键词：
D O I：
10.1007/s40278-017-28980-5
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1 / 1
相关论文
共 50 条
  • [31] Conventional and biological DMARD-related ADRs
    [J]. Reactions Weekly, 2024, 2004 (1) : 8 - 8
  • [32] Antipsychotic-related severe cardiovascular ADRs
    [J]. Reactions Weekly, 2019, 1772 (1) : 7 - 7
  • [33] TGA seeks comments on naming of biological products
    [J]. Reactions Weekly, 2017, 1664 (1) : 6 - 6
  • [34] TGA: no quality issues with homeopathic teething products
    [J]. Reactions Weekly, 2017, 1639 (1) : 5 - 5
  • [35] TGA updates on regulatory status of dextropropoxyphene products
    [J]. Reactions Weekly, 2012, 1390 (1) : 3 - 3
  • [36] Regulatory changes in China on xenotransplantation and related products
    Liu, Yuping
    Qin, Lixia
    Tong, Rongsheng
    Liu, Ting
    Ling, Chen
    Lei, Tiantian
    Zhang, Dingding
    Wang, Yi
    Deng, Shaoping
    [J]. XENOTRANSPLANTATION, 2020, 27 (03)
  • [37] RESEARCH ON CHANGES RELATED TO THE IMPLEMENTATION OF NEW PRODUCTS
    Mihaila, Andreea-Madalina
    Rusu, Costache
    [J]. PERFORMANCE MANAGEMENT OR MANAGEMENT PERFORMANCE?, 2018, : 141 - 149
  • [38] Rivastigmine-related ADRs reported to Lareb (Netherlands)
    [J]. Reactions Weekly, 2014, 1519 (1) : 4 - 4
  • [39] Health Canada warns against unapproved yohimbine-containing products
    [J]. Reactions Weekly, 2006, 1097-1098 (1) : 3 - 3
  • [40] Composition of unapproved cannabinoid products directly marketed to Canadian pet owners
    Chicoine, Alan
    Vuong, Stephanie
    Illing, Kate
    Hare, Jonathan
    Caldwell, Jennifer
    Sandler, Ian
    [J]. CANADIAN VETERINARY JOURNAL-REVUE VETERINAIRE CANADIENNE, 2020, 61 (05): : 477 - 480
12345